Jazz Pharmaceuticals plc (JAZZ)

NASDAQ: JAZZ · Real-Time Price · USD

243.47

-4.06 (-1.64%)

At close: Jul 20, 2026, 4:00 PM EDT

243.01

-0.46 (-0.19%)

Pre-market: Jul 21, 2026, 4:37 AM EDT

Jazz Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	15,294	10,444	7,467	7,657	10,071	7,852
Market Cap Growth	119.85%	39.87%	-2.49%	-23.96%	28.26%	-15.31%
Enterprise Value	17,837	13,411	10,621	11,803	14,985	13,398
Last Close Price	243.47	170.00	123.15	123.00	159.31	127.40
PE Ratio	519.29	-	14.24	20.16	-	-
Forward PE	9.90	7.67	5.72	6.29	8.54	8.23
PEG Ratio	0.18	0.55	0.37	0.50	1.14	0.62
PS Ratio	3.45	2.45	1.84	2.00	2.75	2.54
PB Ratio	3.37	2.42	1.82	2.05	3.26	1.98
P/FCF Ratio	12.05	8.05	5.50	7.17	8.10	10.46
P/OCF Ratio	11.46	7.70	5.35	7.01	7.92	10.09
EV/Sales Ratio	4.02	3.14	2.61	3.08	4.10	4.33
EV/EBITDA Ratio	8.88	50.41	7.72	9.70	26.57	18.54
EV/EBIT Ratio	13.77	-	14.82	20.40	-	78.68
EV/FCF Ratio	14.05	10.34	7.82	11.05	12.06	17.84
Debt / Equity Ratio	0.96	1.01	1.49	1.38	1.87	1.54
Debt / EBITDA Ratio	8.00	20.33	4.47	4.74	10.28	8.49
Debt / FCF Ratio	4.26	4.17	4.53	5.40	4.66	8.17
Net Debt / Equity Ratio	0.56	0.69	0.77	1.11	1.59	1.40
Net Debt / EBITDA Ratio	3.74	11.15	2.29	3.41	8.72	7.67
Net Debt / FCF Ratio	1.99	2.29	2.32	3.88	3.95	7.39
Asset Turnover	0.38	0.36	0.35	0.34	0.32	0.33
Inventory Turnover	1.25	1.12	0.83	0.66	0.61	0.78
Quick Ratio	1.65	1.46	3.57	1.52	1.64	1.43
Current Ratio	2.04	1.86	4.46	2.24	2.79	3.23
Return on Equity (ROE)	0.67%	-8.45%	14.35%	12.25%	-6.07%	-8.63%
Return on Assets (ROA)	0.04%	-2.06%	7.31%	7.30%	-0.33%	5.27%
Return on Invested Capital (ROIC)	0.07%	-3.35%	11.31%	10.22%	-0.43%	7.12%
Return on Capital Employed (ROCE)	-0.40%	-4.22%	6.88%	5.86%	-0.61%	1.96%
Earnings Yield	0.19%	-	7.02%	4.96%	-	-
FCF Yield	8.30%	12.42%	18.19%	13.95%	12.34%	9.56%
Buyback Yield / Dilution	5.13%	7.61%	8.41%	-15.23%	-4.77%	-5.62%
Total Shareholder Return	5.13%	7.61%	8.41%	-15.23%	-4.77%	-5.62%

SEC Filings: 10-K · 10-Q